1Open roles

About ORYL Photonics

In drug R&D, a surprising amount of time and budget is lost when promising compounds later fail due to solubility or aggregation. Conventional measurements are often too slow and too compound-intensive for modern screening timelines. At ORYL Photonics, we built the ORYL F1 to make high-throughput, low-compound, plate-based solubility & aggregation profiling practical—delivering decision-ready results in minutes so teams can de-risk earlier, reduce rework, and advance the right molecules with confidence.

Founded in 2020 by Nathan Dupertuis and Orly Tarun.

Founded
2020
Employees
1 to 10
Total funding
$930K
Hiring in
1 city

Leadership

The top of ORYL Photonics's org chart, with how many people report into each leader.

OTPhoto of Orly Tarun

Orly Tarun

CEO and Co-founder

Open roles at ORYL Photonics 1